Abstract:Chronic obstructive pulmonary disease (COPD) is one of the major diseases threatening human life and health. According to the report released by the World Health Organization (WHO) in 2020, COPD has become the third leading cause of death in the world, featuring a sustainable growth of incidence rate as well as population age. The purpose of this review focuses on the advancement of bioactive natural compounds, such as baicalin, quercetin, resveratrol, and curcumin, which demonstrate promising therapeutic/interventional effects on CODP in vitro and in vivo . Information emphasizing on COPD was systematically collected from several authoritative internet databases including Web of Science, PubMed, Elsevier, Wiley Online Library, and Europe PMC, with a combination of keywords containing “COPD” and “natural small molecular compounds”. The new evidence indicated that these valuable molecules featured unique functions in the treatment of COPD through various biological processes such as anti-inflammatory, anti-oxidant, anti-apoptosis, and anti-airway fibrosis. Moreover, we found that the promising effects of these natural compounds on COPD were mainly achieved through JAK3/STAT3/NF-κB and MAPK inflammatory signaling pathways, Nrf2 oxidative stress signaling pathway, and TGF-β1/Smad 2/3 fibrosis signaling pathway, which referenced to multiple targets like TNF-α, IL-6, IL-8, TIMP-1, MMP, AKT, JAK3, IKK, PI3K, HO-1, MAPK, P38, ERK, etc. Current challenges and future directions in this promising field are also discussed at the end of this review. For the convenience of the readers, this review is divided into ten parts according to the structures of potential natural small molecular compounds. We hope that this review brings a quick look and provides some inspiration for the research of COPD.

The Role of Bioactive Small Molecules in COPD Pathogenesis

Identifying targets for COPD treatment through gene expression analyses.

Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and Perspectives

Potential Natural Small Molecular Compounds for the Treatment of Chronic Obstructive Pulmonary Disease: An Overview

The Role of Lysophospholipid Metabolites LPC and LPA in the Pathogenesis of Chronic Obstructive Pulmonary Disease

The Role of Sulfur Compounds in Chronic Obstructive Pulmonary Disease

Inflammatory and Immune Mechanisms in COPD: Current Status and Therapeutic Prospects

Copd_a_196210 1009..1018

The Current Molecular and Cellular Landscape of Chronic Obstructive Pulmonary Disease (COPD): A Review of Therapies and Efforts towards Personalized Treatment

Aspects on pathophysiological mechanisms in COPD

Future Therapeutic Treatment of COPD: Struggle Between Oxidants and Cytokines.

Current Concepts on Oxidative/carbonyl Stress, Inflammation and Epigenetics in Pathogenesis of Chronic Obstructive Pulmonary Disease

Molecular Mechanisms and the Interplay of Important Chronic Obstructive Pulmonary Disease Biomarkers Reveals Novel Therapeutic Targets

Roles of sirtuin family members in chronic obstructive pulmonary disease

Molecular Pathogenesis in Chronic Obstructive Pulmonary Disease and Therapeutic Potential by Targeting AMP‐activated Protein Kinase

Pathophysiology, Therapeutic Targets, and Future Therapeutic Alternatives in COPD: Focus on the Importance of the Cholinergic System

Lipid Metabolism In Chronic Obstructive Pulmonary Disease

The cGAS-STING pathway in COPD: targeting its role and therapeutic potential

Role of Airway Epithelium-Origin Chemokines and Their Receptors in COPD~!2009-12-20~!2010-03-18~!2010-04-16~!

Mechanisms of steroid resistance in chronic obstructive pulmonary disease

COPD: preclinical models and emerging therapeutic targets